196 related articles for article (PubMed ID: 9240110)
21. Costs of breast cancer and the cost-effectiveness of breast cancer screening.
Elixhauser A
Int J Technol Assess Health Care; 1991; 7(4):604-15. PubMed ID: 1778705
[TBL] [Abstract][Full Text] [Related]
22. The cost-effectiveness of cervical-vaginal rescreening.
Raab SS
Am J Clin Pathol; 1997 Nov; 108(5):525-36. PubMed ID: 9353091
[TBL] [Abstract][Full Text] [Related]
23. Assessment of cervical cancer screening and follow-up programs.
Celentano DD; deLissovoy G
Public Health Rev; 1989-1990; 17(2-3):173-240. PubMed ID: 2518819
[TBL] [Abstract][Full Text] [Related]
24. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
26. [Simultaneous screening of cancers of the breast, cervix, colon and rectum. The Isère experience].
Exbrayat C; Garnier A; Bolla M; Winckel P; Salicru B; Marron J; Faure H; Menegoz F; Billette de Villemeur A
Bull Cancer; 1996 Aug; 83(8):641-8. PubMed ID: 8869044
[TBL] [Abstract][Full Text] [Related]
27. Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.
Coughlin SS; Thompson TD; Hall HI; Logan P; Uhler RJ
Cancer; 2002 Jun; 94(11):2801-12. PubMed ID: 12115366
[TBL] [Abstract][Full Text] [Related]
28. Clinical and cost implications of new technologies for cervical cancer screening: the impact of test sensitivity.
Hutchinson ML; Berger BM; Farber FL
Am J Manag Care; 2000 Jul; 6(7):766-80. PubMed ID: 11067374
[TBL] [Abstract][Full Text] [Related]
29. Health insurance and cancer screening among women.
Makuc DM; Freid VM; Parsons PE
Adv Data; 1994 Aug; (254):1-12. PubMed ID: 10138738
[No Abstract] [Full Text] [Related]
30. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
31. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
[TBL] [Abstract][Full Text] [Related]
32. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
33. Costs and benefits of cervical screening. III. Cost/benefit analysis of a call of previously unscreened women.
Waugh N; Smith I; Robertson A; Reid GS; Halkerston R; Grant A
Cytopathology; 1996 Aug; 7(4):249-55. PubMed ID: 8853971
[TBL] [Abstract][Full Text] [Related]
34. State Medicaid expansion decisions and disparities in women's cancer screening.
Sabik LM; Tarazi WW; Bradley CJ
Am J Prev Med; 2015 Jan; 48(1):98-103. PubMed ID: 25441234
[TBL] [Abstract][Full Text] [Related]
35. Health Reform, Medicaid Expansions, and Women's Cancer Screening.
Ku L; Bysshe T; Steinmetz E; Bruen BK
Womens Health Issues; 2016; 26(3):256-61. PubMed ID: 26926159
[TBL] [Abstract][Full Text] [Related]
36. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
37. Comparative cost-effectiveness of HPV vaccines in the prevention of cervical cancer in Malaysia.
Ezat SW; Aljunid S
Asian Pac J Cancer Prev; 2010; 11(4):943-51. PubMed ID: 21133606
[TBL] [Abstract][Full Text] [Related]
38. Cost-effectiveness of breast cancer screening in Spain.
Plans P; Casademont L; Salleras L
Int J Technol Assess Health Care; 1996; 12(1):146-50. PubMed ID: 8690555
[TBL] [Abstract][Full Text] [Related]
39. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States).
Tangka FK; Dalaker J; Chattopadhyay SK; Gardner JG; Royalty J; Hall IJ; DeGroff A; Blackman DK; Coates RJ
Cancer Causes Control; 2006 Nov; 17(9):1145-54. PubMed ID: 17006720
[TBL] [Abstract][Full Text] [Related]
40. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
